All posts tagged "Remethinostat"

Remethinostat, an HDAC inhibitor associated with positive clinical outcomes in patients with basal cell carcinoma

BCC is the most common form of skin cancer and is usually treated with surgical resection. However, studies have shown that resection can be a costly...